These findings suggest that ambroxol acts as a chemical chaperone that modulates lysosomal functions, in which increase of Sap C level is involved, providing a potential target for innovative therapeutic strategies for PD (Figure 3). The gene discussed is CCSAP; the disease is Parkinson disease.